Powered by ZigaForm version 3.9.8.8

Application for Clinical Trials

Product Details

Title of Study: A multi-country, multi-centre, two arm, parallel, double blind, placebo- controlled, randomized trial of antenatal corticosteriods for women at risk of imminent birth in the late preterm period in hospitals in low resource countries to improve newborn out

Subtitle: ACTION II Trial

Protocol; Version: A65916; 1.5

Phase of Study: Phase 3;

Study Type: grant aided study

Approval Date:

Applicant Name: Dr Adejumoke Idowu Ayede

Address: Department of Pediatrics, University College Hospital, Ibadan

Date of Application: 2017-09-06

Applicant Name: Dr Adejumoke Idowu Ayede

Sponsor: Department of Reproductive Health & Research, World Health Organisation

Address of Sponsor: Avenue Appia 20 1211 Geneva 27 Switzerland

Trial Sites: 1. University College Hospital, Ibadan 2. Mother & Child Hospital, Akure 3. State Specialist Hospital, Akure 4. Nyanya General Hospital, Abuja 5. Lagos Island Maternity Hospital, Lagos 6. Kubwa General Hospital, Abuja 7. Lagos State University Teaching H

Product Type: Drug

Status of Approval:


Was this post helpful?